Prostate Cancer Channel

Brought to you by Oncology Times

A collection of timely studies, news, treatment options and more is presented in this concise, invaluable resource.

Resource Library

Articles

Find the latest in prostate cancer research and developments in this continually updated collection of articles.

Videos

Experts share insights into prostate cancer trends, progress, and breakthroughs.

Blog

Exclusive commentary on prostate cancer is presented by leaders in the industry.

Additional Resources

Download the Understanding Prostate Cancer anatomical chart.

FDA Approves Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer

The FDA approved a supplemental New Drug Application (sNDA) for enzalutamide, following FDA Priority Review designation, based on results from the phase III PROSPER trial. The FDA action broadens the indication for enzalutamide to men with castration-resistant prostate cancer (CRPC), now including men with non-metastatic CRPC.

Wolters Kluwer
- Wolters Kluwer, Inc.

When you have to be right